Therapeutic Innovations

The Therapeutic Innovation axis is organized in 2 integrated work packages which are translational from basic science to clinics. WP1 (ORPHEE) is focused on immune cells reprogramming for cancer therapy through macrophages reactivation (MACBETH, MAC-CAR, ESCULAPE) and WP2 (Caron: Caron on Oncology) is devoted to clinical application of in clinic (GLIOMIC, OMERIC) and more recently (MONET (MSCA), NANOTUMORS (AVIESAN PFA)).